Equine Acute Blood Loss Study Guide

Overview and Clinical Importance

Acute blood loss in horses represents a medical emergency requiring rapid recognition and intervention. Unlike small animals, horses have unique physiological adaptations including a splenic reservoir capable of mobilizing erythrocytes during stress, which can initially mask the severity of hemorrhage. The average adult horse (450-500 kg) has approximately 40 liters of blood (8% of body weight), and can tolerate up to 25% blood volume loss before showing severe signs of hypovolemic shock.

Understanding the etiology, pathophysiology, clinical presentation, and management of acute hemorrhage is essential for equine practitioners and frequently tested on the NAVLE. This guide covers common causes including periparturient hemorrhage, guttural pouch mycosis, traumatic injury, splenic rupture, and hemoperitoneum from various sources.

Pathophysiology of Hemorrhagic Shock

Hemorrhagic shock occurs when blood loss leads to inadequate tissue perfusion and oxygen delivery. The horse's physiological response involves multiple compensatory mechanisms that can initially mask severity.

Compensatory Mechanisms

Splenic Contraction: The equine spleen stores approximately 30-50% of circulating erythrocytes. Sympathetic stimulation causes splenic contraction, releasing stored RBCs and potentially doubling the PCV within minutes. This adaptation can mask early hemorrhage by maintaining or even increasing PCV despite significant blood loss. PCV may take 12-36 hours to return to true baseline after acute hemorrhage.

Cardiovascular Response: Baroreceptor activation triggers increased heart rate, peripheral vasoconstriction, and venoconstriction to maintain cardiac preload. Blood flow is preferentially shunted to vital organs (brain, heart) at the expense of peripheral tissues, skin, and splanchnic circulation.

Neuroendocrine Response: The renin-angiotensin-aldosterone system (RAAS) is activated, promoting sodium and water retention. ADH secretion increases water reabsorption. Catecholamine release enhances cardiac contractility and vasoconstriction.

Fluid Shifts: Transcapillary fluid refill moves interstitial fluid into the vascular space, diluting remaining blood components. This explains why PCV and total protein often decrease over hours following acute hemorrhage as plasma volume is restored but erythrocyte mass is not.

Classification of Hemorrhagic Shock

Hemorrhagic shock in horses is classified by percentage of blood volume lost and corresponding clinical signs:

Common Etiologies of Acute Blood Loss

1. Periparturient Hemorrhage

Periparturient hemorrhage (PPH) is the most common cause of acute fatal blood loss in mares, accounting for up to 40% of periparturient mare deaths. The condition occurs most frequently within 24 hours of foaling and primarily involves rupture of the uterine artery.

Risk Factors

• Older multiparous mares (greater than 15 years): 78% of cases occur in mares 15 years or older
• Multiple previous foalings: median of 8 previous foals in affected mares
• Arterial wall degeneration: smooth muscle atrophy, medial fibrosis, elastic lamina calcification
• Draft breeds may have increased risk due to body size

Anatomy and Pathogenesis

The middle uterine artery is most commonly affected (approximately 80% of cases), typically rupturing within 15 cm of its bifurcation from the external iliac artery. Other affected vessels include the external iliac artery, utero-ovarian artery, and vaginal artery. Hemorrhage may be contained within the broad ligament (forming a hematoma) or rupture into the peritoneal cavity causing hemoabdomen.

Clinical Signs

• Early signs: Colic, restlessness, flank watching, Flehmen response
• Progressive signs: Tachycardia, tachypnea, pale mucous membranes, sweating
• Compulsive thirst: Characteristic sign due to CNS hypoperfusion and RAAS activation
• Late signs: Weakness, collapse, depression, cold extremities

Diagnosis

• Transrectal palpation: Large, firm, painful mass in broad ligament
• Transabdominal/transrectal ultrasound: Hyperechoic swirling fluid (hemoabdomen), heterogeneous mass (hematoma)
• Abdominocentesis: Sanguineous fluid, PCV of peritoneal fluid approaching or exceeding peripheral PCV
• Serial PCV/TP: Progressive decline indicates ongoing hemorrhage

2. Guttural Pouch Mycosis

Guttural pouch mycosis (GPM) is a fungal infection (most commonly Aspergillus fumigatus) affecting the guttural pouches, resulting in erosion of the major blood vessels traversing these structures. It represents a life-threatening condition with fatal hemorrhage occurring in approximately 50% of untreated cases.

Anatomy

The guttural pouches are ventral diverticula of the auditory tubes, divided into medial and lateral compartments by the stylohyoid bone. Critical structures traversing the pouches include the internal carotid artery (ICA), external carotid artery (ECA), maxillary artery, and cranial nerves VII, IX, X, XI, and XII, plus sympathetic fibers.

Clinical Signs

• Epistaxis: Usually unilateral, intermittent, moderate to severe; often bilateral presentation
• Dysphagia: Poor prognostic indicator due to CN IX/X involvement; may lead to aspiration pneumonia
• Horner syndrome: Ptosis, miosis, enophthalmos, patchy cervical sweating (sympathetic damage)
• Laryngeal hemiplegia: Abnormal respiratory noise from recurrent laryngeal nerve damage
• Facial paralysis: CN VII involvement

Diagnosis

Endoscopy is the gold standard, revealing diphtheritic fungal plaques (white, tan, black membranes) overlying affected vessels. Blood or blood clots may be visible at the guttural pouch ostium. Radiographs may show fluid lines in affected pouches or soft tissue masses.

Treatment

• Emergency: Common carotid artery ligation (temporary measure to reduce hemorrhage)
• Definitive: Transarterial coil embolization (TACE) - requires proximal AND distal occlusion due to Circle of Willis collateral flow
• Balloon catheter occlusion of affected artery
• Medical: Topical antifungal lavage (slow response, high hemorrhage risk during treatment)

3. Hemoabdomen (Hemoperitoneum)

Hemoperitoneum refers to blood accumulation within the peritoneal cavity. Causes include periparturient hemorrhage (discussed above), splenic rupture, trauma, neoplasia, ovarian hemorrhage, and idiopathic (approximately 40% of cases).

Common Causes

• Splenic hematoma with capsular rupture: May be traumatic or spontaneous; associated with neoplasia (hemangiosarcoma, lymphosarcoma)
• Blunt abdominal trauma: Kicks, falls, collisions affecting spleen, liver, or mesenteric vessels
• Ovarian hemorrhage: Ruptured corpus hemorrhagicum, granulosa cell tumor
• Mesenteric vascular avulsion: Usually traumatic
• Idiopathic: Significant proportion with no identifiable cause

Clinical Presentation

Horses typically present with signs of colic, pale mucous membranes, tachycardia, tachypnea, depression or anxiety, and cold extremities. Older horses (greater than 13 years) are overrepresented. Respiratory rate greater than 30 breaths/min is associated with poor prognosis.

Diagnosis

• Abdominocentesis: Sanguineous fluid; if abdominal fluid PCV is at least 25% of peripheral PCV, hemorrhage is likely
• Non-clotting blood: Abdominal blood present for greater than 45 minutes does not clot (defibrination)
• Ultrasound: Echogenic swirling fluid, possible identification of source (splenic mass, broad ligament hematoma)
• Serial PCV/TP: Both decrease together in whole blood loss

4. Other Causes of Acute Blood Loss

Progressive Ethmoid Hematoma

A benign, locally destructive mass arising from the ethmoidal labyrinth causing intermittent, unilateral, mild epistaxis. Most common in middle-aged horses (mean 9.9 years), Thoroughbreds overrepresented. Diagnosis by endoscopy (characteristic greenish-yellow to purplish-red mass at nasal fundus). Treatment includes surgical resection, laser ablation, cryosurgery, or intralesional formalin injection. Recurrence rate is 30-60%.

Exercise-Induced Pulmonary Hemorrhage (EIPH)

Occurs in virtually all horses during strenuous exercise due to pulmonary capillary stress failure. Usually causes minimal clinical blood loss but can rarely cause severe epistaxis. Epistaxis occurs in only approximately 5% of affected horses. Diagnosis by post-exercise endoscopy (blood in tracheobronchial tree) or BAL cytology (hemosiderophages). Management with furosemide (4-hour pre-exercise) is common in racehorses.

Traumatic Hemorrhage

External hemorrhage from lacerations, surgical complications, or castration. Internal hemorrhage from basilar skull fractures (rearing over backward), pelvic fractures, or organ rupture. Management focuses on hemostasis (pressure, ligatures, topical hemostats) and volume replacement.

Coagulopathies

Disseminated intravascular coagulation (DIC) secondary to sepsis, endotoxemia, or severe disease. Hemophilia A (Factor VIII deficiency) is rare but reported in Arabians, Thoroughbreds, and Standardbreds (sex-linked recessive). Purpura hemorrhagica following Streptococcus equi infection or vaccination can cause hemorrhage from immune-mediated vasculitis.

Diagnostic Approach

Clinicopathologic Findings

Treatment and Management

Controlled vs. Uncontrolled Hemorrhage

Controlled hemorrhage: Bleeding that can be stopped by direct pressure, ligatures, or surgical intervention. Treatment focuses on rapid volume restoration.

Uncontrolled hemorrhage: Vascular breach that cannot be controlled (e.g., internal arterial rupture). Aggressive fluid resuscitation may worsen bleeding by increasing blood pressure. Use permissive hypotension strategy until surgical control is achieved.

Fluid Therapy

Calculating Blood Loss

Blood Volume = 80 mL/kg (8% body weight) | For 450 kg horse: 36-40 L total blood volume Blood Deficit (L) = [(Normal PCV - Current PCV) / Normal PCV] x 0.08 x Body Weight (kg) Transfusion volume: Every 2.2 mL whole blood/kg increases PCV by approximately 1%

Blood Transfusion

Transfusion Triggers

• PCV less than 12-15% with clinical signs of tissue hypoxia
• Persistent tachycardia (greater than 60 bpm) despite crystalloid resuscitation
• Rising blood lactate despite volume replacement
• Oxygen extraction ratio greater than 40%
• Clinical signs: Pale/white mucous membranes, weakness, depression, cold extremities

Donor Selection

• Ideal donor: Large (greater than 350 kg), healthy gelding with PCV greater than 35%
• Blood type: Ideally Aa and Qa antigen-negative (more common in Quarter Horses, Standardbreds, Morgans)
• Testing: EIA-negative (Coggins test), ideally negative for EVA, parvovirus, hepacivirus
• Collection: Up to 8 L from 450 kg donor (approximately 15-20% blood volume)

Crossmatching

Horses have 8 blood groups (A, C, D, K, P, Q, U, T) with over 400,000 possible phenotypes - NO universal donor exists. However, horses lack significant naturally occurring alloantibodies, making first transfusions relatively safe without crossmatching. Crossmatching is recommended for: horses with prior transfusions, mares that have foaled (sensitized during pregnancy), and any subsequent transfusions.

Ancillary Treatments

Memory Aids and Clinical Pearls

Mnemonic: BLEED for Hemorrhagic Shock Assessment

• Blood pressure - decreased or thready pulse
• Lactate - elevated indicates tissue hypoxia
• Extremities - cold (peripheral vasoconstriction)
• Elevated heart rate (greater than 60 bpm concerning)
• Decreased PCV/TP (serial measurements most useful)

Mnemonic: OLD MARE for PPH Risk Factors

• Older age (greater than 15 years)
• Large body size
• Degeneration of arterial walls
• Multiple previous foalings (multiparity)
• Artery - middle uterine most commonly affected
• Respiratory rate elevation = poor prognosis
• Early treatment improves survival (84% with prompt care)

Key Numbers to Remember

• 40 liters: Approximate blood volume in 500 kg horse
• 25%: Blood loss tolerated before severe shock
• 40%: Blood loss typically fatal
• 12-15%: PCV transfusion trigger (with clinical signs)
• 50%: Mortality rate in untreated GPM with epistaxis
• 84%: Survival rate for PPH with early treatment near referral
• 2-6 weeks: Time for bone marrow to restore RBC numbers